$18.58
-0.30-1.59%
Últ. Act.: Nov 5, 4:01 PM
Odyssey Therapeutics (ODTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Estimate | $-0.97 | $-0.85 | $-1.29 |
| Actual | $-1.10 | $-1.74 | $-6.77 |
| Surprise | -13.4% | -104.7% | -424.8% |
| Revenue | |||
| Estimate | — | — | — |
| Actual | $0 | $0 | $0 |
| Surprise | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.03 | $-1.22 | $-1.32 | $-1.42 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-1.10 | $-0.97 | -13.4 % |
| Q2 | Aug 4, 2026 | $-1.74 | $-0.85 | -104.7 % |
| Q1 | Jun 17, 2026 | $-6.77 | $-1.29 | -424.8 % |